Products and Services (Tables)

3 Months Ended

Mar. 31, 2015

Products and Services [Abstract]

Revenue by product category

The following tables set forth, for the periods indicated, net revenue by product category along with the percent change from the previous period:

	Three Months Ended March 31,
	2015					2014
	Net Revenue		Percent Change			Net Revenue		Percent  Change
Catheter products	$	23,857,000		24	%	$	19,164,000		15	%
Hemostat products		6,177,000		3	%		5,997,000		4	%
Vein products and services		4,407,000		(6	%)		4,684,000		31	%
Total product revenue		34,441,000		15	%		29,845,000		15	%
License		170,000		173	%		62,000		(29	%)
Total revenue	$	34,611,000		16	%	$	29,907,000		15	%

The following tables set forth, for the periods indicated, net revenue by product line along with the percent change from the previous period for each of the Company’s top seven products by net revenue:

		Three months ended March 31,
		2015					2014
Product Line	Primary Market	Net Revenue		Percent Change			Net Revenue
GuideLiner catheters	Interventional cardiology	$	10,340,000		54	%	$	6,703,000
Pronto catheters	Interventional cardiology		4,382,000		(6	%)		4,676,000
Hemostatic patches	Interventional cardiology		3,022,000		(4	%)		3,164,000
Micro-introducer kits	Interventional radiology		2,854,000		22	%		2,333,000
Vein catheter reprocessing	Phlebology		2,712,000		1	%		2,680,000
Radial access products	Interventional cardiology		1,638,000		23	%		1,333,000
D-Stat Flowable hemostat	Electrophysiology		1,371,000		1	%		1,352,000